US EditionCovid-19: Anvisa approves registration of monovalent Spikevax vaccine
Summary by EBC
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Covid-19: Anvisa approves registration of monovalent Spikevax vaccine
The National Health Surveillance Agency (Anvisa) announced on Wednesday (6), in Brasília, the registration of the Spikevax vaccine, a single-valent dose against Covid-19. According to the agency, the immunizer is updated to protect against the XBB 1.5 variant of Covid, popularly known as Kraken. The product is registered by the company Adium S.A. and manufactured by Moderna. According to Anvisa, this is the second single-valent updated vaccine w…
·Quadra, Brazil
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
